drug repurposing Archive — Page 1 of 2

August 4, 2026

Research that reaches patients: A conversation with Wesley Self and Jill Pulley

Research and art both approach the world with a fresh perspective. This art gallery features work by undergraduate student artists who participated in the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. Supported by the Burroughs Wellcome Fund, the VI4-AiR program brings together scientists and artists to create and promote art as a visual science communication tool.

June 25, 2026

Common asthma drugs may help guide new treatments for Parkinson’s disease

New research findings suggest that drugs approved by the Food and Drug Administration for other conditions might be repurposed to restore normal cell function in neurodegenerative disorders such as Parkinson’s disease.

By Bill Snyder
June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

By Bill Snyder
April 20, 2026

Drug lifts ‘brain fog’ from lupus patients: Clinical trial

An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. The EG501 study was the inaugural project of Vanderbilt Health’s Drug Repurposing program.

By Bill Snyder
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

By Leigh MacMillan
February 26, 2024

Study finds a role for AI in drug repurposing pipeline

Vanderbilt researchers are using artificial intelligence to search for existing drugs used for other problems that might help patients Alzheimer’s Disease.

By Paul Govern